References
- Arvisais EW, Romanelli A, Hou X, Davis JS. 2006. AKTindependent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2alpha. J Biol Chem 281:26904-26913 https://doi.org/10.1074/jbc.M605371200
- Bianchi L, Volpato S. 2016. Muscle dysfunction in type 2 diabetes: a major threat to patient's mobility and independence. Acta Diabetol 53:1-11 https://doi.org/10.1007/s00592-015-0830-0
- Cohen S, Nathan JA, Goldberg AL. 2015. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14:58-74 https://doi.org/10.1038/nrd4467
- Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. 2010. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13:1-7 https://doi.org/10.1097/MCO.0b013e328333c1c1
- Ehrenborg E, Krook A. 2009. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev 61:373-393 https://doi.org/10.1124/pr.109.001560
- Frontera WR, Ochala J. 2015. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int 96:183-195 https://doi.org/10.1007/s00223-014-9915-y
- Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98:14440-14445 https://doi.org/10.1073/pnas.251541198
- Jackman RW, Kandarian SC. 2004. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287:C834-843 https://doi.org/10.1152/ajpcell.00579.2003
- Jeong J, Park CH, Kim IB, Kim YH, Yoon JM, Kim KS, Kim JB. 2017. Korean mistletoe (Viscum album coloratum) extract regulates gene expression related to muscle atrophy and muscle hypertrophy. BMC Complement Alternat Med 17:68-77 https://doi.org/10.1186/s12906-017-1575-9
- Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW, Lee KW, Kim DW, Kang SB, Kim KI, Kim CH, Kim JH. 2015. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23:687-694 https://doi.org/10.1007/s00520-014-2418-6
- Jung HY, Lee AN, Song TJ, An HS, Kim YH, Kim KD, Kim IB, Kim KS, Han BS, Kim CH, Kim KS, Kim JB. 2012. Korean mistletoe (Viscum album coloratum) extract improves endurance capacity in mice by stimulating mitochondrial activity. J Med Food 15:621-628 https://doi.org/10.1089/jmf.2010.1469
- Jung HY, Kim YH, Kim IB, Jeong JS, Lee JH, Do MS, Jung SP, Kim KS, Kim KT, Kim JB. 2013. The Korean mistletoe (Viscum album coloratum) extract has an antiobesity effect and protects against hepatic steatosis in mice with high-fat diet-induced obesity. Evid Based Complement Alternat Med 168207
- Kienle GS, Kiene H. 2010. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 9:142-157 https://doi.org/10.1177/1534735410369673
- Kim IB, Jeong JS, Yoon TJ, Kim JB. 2013. Safety evaluation of Korean mistletoe extract. Korean J Food and Nutr 26: 383-390 https://doi.org/10.9799/ksfan.2013.26.3.383
- Kim KW, Yang SH, Kim JB. 2014. Protein fractions from Korean mistletoe (Viscum album coloratum) extract induce insulin secretion from pancreatic beta cells. Evid Based Complement Alternat Med e703624
- Kunkel SD, Elmore CJ, Bongers KS, Ebert SM, Fox DK, Dyle MC, Bullard SA, Adams CM. 2012. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One 7:e39332 https://doi.org/10.1371/journal.pone.0039332
- Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280: 2737-2744 https://doi.org/10.1074/jbc.M407517200
- Lee SH, An HS, Jung YW, Lee EJ, Lee HY, Choi ES, An SW, Son H, Lee SJ, Kim JB, Min KJ. 2014. Korean mistletoe (Viscum album coloratum) extract extends the lifespan of nematodes and fruit flies. Biogerontology 15:153-164 https://doi.org/10.1007/s10522-013-9487-7
- Magnuson B, Ekim B, Fingar DC. 2012. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441:1-21 https://doi.org/10.1042/BJ20110892
- Nader GA. 2005. Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int J Biochem Cell Biol 37: 1985-1996 https://doi.org/10.1016/j.biocel.2005.02.026
- Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, Sonenberg N, Kelly PA, Sotiropoulos A, Pende M. 2005. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol 7:286-294 https://doi.org/10.1038/ncb1231
- Rosenberg IH. 1997. Sarcopenia: origins and clinical relevance. J Nutr 127:990S-991S https://doi.org/10.1093/jn/127.5.990S
- Rossi P, Marzani B, Giardina S, Negro M, Marzatico F. 2008. Human skeletal muscle aging and the oxidative system: cellular events. Curr Aging Sci 1:182-191 https://doi.org/10.2174/1874609810801030182
- Sandri M. 2008. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160-170 https://doi.org/10.1152/physiol.00041.2007
- Schiaffino S, Mammucari C. 2011. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 1:4 https://doi.org/10.1186/2044-5040-1-4
- Stefanovsky V, Langlois F, Gagnon-Kugler T, Rothblum LI, Moss T. 2006. Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling. Mol Cell 21:629-639 https://doi.org/10.1016/j.molcel.2006.01.023
- Strniskova M, Barancik M, Ravingerova T. 2002. Mitogenactivated protein kinases and their role in regulation of cellular processes. Gen Physiol Biophys 21:231-255
- Won HS. 1991. Age-related changes in body growth, muscle protein content and cellular-mediated immunity and rats fed stock diets. Korean J Food and Nutr 4:133-139
- Zarogoulidis P, Lampaki S, Turner JF, Huang H, Kakolyris S, Syrigos K, Zarogoulidis K. 2014. mTOR pathway: A current, up-to-date mini-review (Review). Oncol Lett 8:2367-2370 https://doi.org/10.3892/ol.2014.2608